EFFICACY AND SAFETY OF ANIFROLUMAB IN PATIENTS WITH MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF THE SECOND PHASE 3 RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Morand, Eric F. [1 ]
Furie, Richard [2 ]
Tanaka, Yoshiya [3 ]
Bruce, Ian N. [4 ]
Askanase, Anca D. [5 ]
Richez, Christophe [6 ]
Bae, Sang-Cheol [7 ]
Brohawn, Mr Philip Z. [8 ]
Pineda, Lilia [8 ]
Berglind, Anna [9 ]
Tummala, Raj [8 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
[2] Zucker Sch Med Hofstra Northwell, Great Neck, NY USA
[3] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[4] Univ Manchester, Manchester, Lancs, England
[5] Columbia Univ, Coll Phys & Surg, New York, NY USA
[6] CHU Bordeaux GH Pellegrin, Bordeaux, France
[7] Hanyang Univ Hosp Rheumat Dis, Seoul, South Korea
[8] AstraZeneca, Gaithersburg, MD USA
[9] AstraZeneca, Gothenburg, Sweden
来源：
INTERNAL MEDICINE JOURNAL | 2020年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-68
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [32] ANIFROLUMAB REDUCES DISEASE ACTIVITY IN MULTIPLE ORGAN DOMAINS IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Merrill, J.
    Furie, R.
    Werth, V.
    Khamashta, M.
    Drappa, J.
    Wang, L.
    Illei, G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S4 - S4
  • [33] Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
    Furie, Richard
    Khamashta, Munther
    Merrill, Joan T.
    Werth, Victoria P.
    Kalunian, Kenneth
    Brohawn, Philip
    Illei, Gabor G.
    Drappa, Jorn
    Wang, Liangwei
    Yoo, Stephen
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 (02) : 376 - 386
  • [34] ANIFROLUMAB REDUCES DISEASE ACTIVITY IN MULTIPLE ORGAN DOMAINS IN MODERATE TO SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
    Merrill, J. T.
    Furie, R.
    Werth, V. P.
    Khamashta, M.
    Drappa, J.
    Wang, L.
    Illei, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 293 - 293
  • [35] Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo-controlled trial in North East Asia
    Suh, Chang-Hee
    Lee, Yoonhee
    Yoo, Sang-Bae
    Quasny, Holly
    Rojas, Aldo Amador Navarro
    Hammer, Anne
    Song, Yeong-Wook
    Kang, Young Mo
    Cho, Chul-Soo
    Park, Won
    Kwok, Seung-Ki
    Lee, Seung-Geun
    Chung, Won Tae
    Bae, Sang-Cheol
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [36] EFFICACY AND SAFETY OF TABALUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM 2 PHASE 3, 52-WEEK, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Isenberg, D.
    Merrill, J.
    Hoffman, R.
    Linnik, M.
    Morgan-Cox, M.
    Veenhuizen, M.
    Iikuni, N.
    Dickson, C.
    Silk, M.
    Wallace, D.
    Doerner, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 141 - 141
  • [37] Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
    Furie, Richard A.
    Morand, Eric F.
    Bruce, Ian N.
    Manzi, Susan
    Kalunian, Kenneth C.
    Vital, Edward M.
    Ford, Theresa Lawrence
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip Z.
    Berglind, Anna
    Tummala, Raj
    [J]. LANCET RHEUMATOLOGY, 2019, 1 (04): : E208 - E219
  • [38] Raloxifene for postmenopausal patients with systemic lupus erythematosus (SLE): A randomized controlled trial
    Mok, CC
    Mak, A
    To, CH
    Ma, KM
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S196 - S197
  • [39] Anifrolumab for the treatment of active systemic lupus erythematosus: a meta-analysis of randomized controlled trials
    Lee, Y. H.
    Song, G. G.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (10): : 988 - 994
  • [40] Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China
    Le Zhang
    Shikai Geng
    Liping Qian
    Shuang Ye
    Xiaodong Wang
    Guohong Lu
    Yang Ding
    Ting Li
    [J]. International Journal of Clinical Pharmacy, 2019, 41 : 1247 - 1255
12345